Logo image of ART.DE

ARTNET AG - REG (ART.DE) Stock Fundamental Analysis

FRA:ART - Deutsche Boerse Ag - DE000A1K0375 - Common Stock - Currency: EUR

11.3  0 (0%)

Fundamental Rating

1

Overall ART gets a fundamental rating of 1 out of 10. We evaluated ART against 52 industry peers in the Specialty Retail industry. ART has a bad profitability rating. Also its financial health evaluation is rather negative. ART is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ART had negative earnings in the past year.
In the past year ART had a positive cash flow from operations.
In multiple years ART reported negative net income over the last 5 years.
In the past 5 years ART always reported a positive cash flow from operatings.
ART.DE Yearly Net Income VS EBIT VS OCF VS FCFART.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1M -1M 2M

1.2 Ratios

With a Return On Assets value of -7.94%, ART is not doing good in the industry: 80.39% of the companies in the same industry are doing better.
ART has a Return On Equity of -27.51%. This is amonst the worse of the industry: ART underperforms 80.39% of its industry peers.
Industry RankSector Rank
ROA -7.94%
ROE -27.51%
ROIC N/A
ROA(3y)-4.83%
ROA(5y)0.64%
ROE(3y)-12.92%
ROE(5y)0.22%
ROIC(3y)N/A
ROIC(5y)N/A
ART.DE Yearly ROA, ROE, ROICART.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60 80

1.3 Margins

ART has a better Gross Margin (56.64%) than 80.39% of its industry peers.
In the last couple of years the Gross Margin of ART has declined.
ART does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 56.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.93%
GM growth 5Y-1.58%
ART.DE Yearly Profit, Operating, Gross MarginsART.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

More info and screens

2

2. Health

2.1 Basic Checks

ART does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ART has more shares outstanding
Compared to 5 years ago, ART has more shares outstanding
The debt/assets ratio for ART has been reduced compared to a year ago.
ART.DE Yearly Shares OutstandingART.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M
ART.DE Yearly Total Debt VS Total AssetsART.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M

2.2 Solvency

ART has an Altman-Z score of -0.69. This is a bad value and indicates that ART is not financially healthy and even has some risk of bankruptcy.
ART's Altman-Z score of -0.69 is on the low side compared to the rest of the industry. ART is outperformed by 76.47% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that ART is not too dependend on debt financing.
ART's Debt to Equity ratio of 0.01 is amongst the best of the industry. ART outperforms 96.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -0.69
ROIC/WACCN/A
WACC7.1%
ART.DE Yearly LT Debt VS Equity VS FCFART.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M 4M

2.3 Liquidity

ART has a Current Ratio of 0.37. This is a bad value and indicates that ART is not financially healthy enough and could expect problems in meeting its short term obligations.
ART has a Current ratio of 0.37. This is amonst the worse of the industry: ART underperforms 92.16% of its industry peers.
ART has a Quick Ratio of 0.37. This is a bad value and indicates that ART is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.37, ART is not doing good in the industry: 76.47% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.37
Quick Ratio 0.37
ART.DE Yearly Current Assets VS Current LiabilitesART.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for ART have decreased strongly by -926.17% in the last year.
The Revenue has decreased by -6.71% in the past year.
ART shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.16% yearly.
EPS 1Y (TTM)-926.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%138.46%
Revenue 1Y (TTM)-6.71%
Revenue growth 3Y3.78%
Revenue growth 5Y4.16%
Sales Q2Q%-2.59%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ART.DE Yearly Revenue VS EstimatesART.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
ART.DE Yearly EPS VS EstimatesART.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 0 0.02 -0.02 -0.04 -0.06

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ART reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ART.DE Price Earnings VS Forward Price EarningsART.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ART indicates a slightly more expensive valuation: ART is more expensive than 72.55% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 83.45
ART.DE Per share dataART.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ART!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ARTNET AG - REG

FRA:ART (8/8/2025, 7:00:00 PM)

11.3

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)08-04 2025-08-04
Earnings (Next)09-22 2025-09-22
Inst Owners0.29%
Inst Owner ChangeN/A
Ins Owners44%
Ins Owner ChangeN/A
Market Cap64.52M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.76
P/FCF N/A
P/OCF 137.93
P/B 17.67
P/tB N/A
EV/EBITDA 83.45
EPS(TTM)-0.18
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)0.08
OCFY0.73%
SpS4.09
BVpS0.64
TBVpS-0.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.94%
ROE -27.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 56.64%
FCFM N/A
ROA(3y)-4.83%
ROA(5y)0.64%
ROE(3y)-12.92%
ROE(5y)0.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.93%
GM growth 5Y-1.58%
F-Score3
Asset Turnover1.85
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA 0.06
Cap/Depr 86.8%
Cap/Sales 6.99%
Interest Coverage N/A
Cash Conversion 59.01%
Profit Quality N/A
Current Ratio 0.37
Quick Ratio 0.37
Altman-Z -0.69
F-Score3
WACC7.1%
ROIC/WACCN/A
Cap/Depr(3y)93.08%
Cap/Depr(5y)87.53%
Cap/Sales(3y)6.1%
Cap/Sales(5y)5.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-926.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%138.46%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.71%
Revenue growth 3Y3.78%
Revenue growth 5Y4.16%
Sales Q2Q%-2.59%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y33.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-188.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-81.11%
OCF growth 3Y-31.08%
OCF growth 5Y-3.16%